Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

NCT00006244 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Refractory Multiple Myeloma
Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

DRUG: melphalan
BIOLOGICAL: recombinant interferon alfa
BIOLOGICAL: aldesleukin
PROCEDURE: in vitro-treated peripheral blood stem cell transplantation

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]